Frank Liang, Ph.D.

Director of Research, Cell Engineering

Dr. Liang leads Refuge’s cell engineering efforts. With more than 15 years in the pharmaceutical and biotech industries, he has held senior scientist roles at companies including Gilead, PDL Biopharma and Johnson & Johnson. Dr. Liang has directed multiple CAR-T programs from discovery to pre-IND phase, and has specialized experience with immunotherapy, particularly T-cell therapy, immuno-oncology and therapeutic antibody development. He holds a Ph.D. from the Institute of Basic Medical Sciences, Beijing, and completed post-doctoral research at University of California, San Francisco.

2018 © Refuge Biotechnologies Inc